SCHEMBL4564375

SCHEMBL4564375

Cc1ccc(S(=O)(=O)N(C(=O)C2NCC(=O)SC2=O)[C@@H](Cc2ccc(OC(=O)N3CCOCC3)cc2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALOX5 P09917 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
P2RX7 Q99572 2/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 3/20 0.33
NPY2R P49146 2/20 0.33
GAA P10253 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
BMP1 P13497 1/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563434 0.94 P2RX7 (0.36) CYP1A2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL4562546 0.91 CYP2C9 (0.43) CYP1A2CYP2C9CYP2C19ALOX5RAB9A
SCHEMBL7579993 0.87 P2RX7 (0.32) P2RX7
SCHEMBL3869878 0.81 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19ALOX5RAB9A
SCHEMBL3859251 0.79 P2RX7 (0.38) CYP1A2CYP2C9CYP2C19L3MBTL1P2RX7
SCHEMBL5655126 0.79 CYP2C9 (0.39) CYP1A2CYP2C9CYP2C19ALOX5RAB9A
SCHEMBL3850655 0.78 P2RX7 (0.40) L3MBTL1P2RX7MEN1KMT2AALDH1A1
SCHEMBL4564688 0.77 BMP1 (0.30) BMP1
SCHEMBL4563644 0.77 PTGES (0.35) ALOX5P2RX7KMT2AALDH1A1
SCHEMBL4563287 0.76 RORC (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635822-A4 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARM INC (US) 2009-06-24 EP disclosed
EP-1635822-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
WO-2005000246-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARMACEUTICALS, INC. (US) 2005-01-06 WO disclosed